Eledon Pharmaceuticals, Inc. was added to several prominent Russell Indexes on June 30, 2025. The company's stock, traded under the ticker ELDN, was included in the Russell 3000 Growth Index, the Russell Small Cap Comp Value Index, and the Russell Small Cap Completeness Index.
Inclusion in these widely followed indexes can enhance the company's profile within the investment community and potentially increase its trading liquidity. This development reflects Eledon's growth and market recognition within the biotechnology sector.
The addition to these indexes means that funds tracking these benchmarks will likely include ELDN in their portfolios, providing a broader investor base for the company's shares.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.